Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Chitnis

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Ropinirole treatment for restless legs syndromeShilpa Chitnis
Neurologic Clinics|December 5, 2008
Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairmentShilpa Chitnis
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Rivastigmine in Parkinson's disease dementiaShilpa Chitnis, Jayaraman Rao
Life Sciences|June 27, 2002
Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cellsShilpa Chitnis, Debasis Mondal, Krishna C Agrawal
Archives of Neurology|August 11, 2010
Deep brain stimulation artifact in needle electromyographyHamid Sadeghian, Shilpa Chitnis, Jeffrey L Elliott
The International Journal of Neuroscience|August 26, 2011
Outcomes from switching from rotigotine patch to alternate therapies in Parkinson's diseaseShilpa Chitnis, Manall Jaffery, Richard B Dewey
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2021
An Online Education Method for Movement Disorders During COVID-19: Opportunity and ExperienceAbhimanyu Mahajan, Rasheda El-Nazer, Shilpa Chitnis
Logopedics, Phoniatrics, Vocology|August 2, 2021
Dysarthria treatment for Parkinson's disease: one-year follow-up of SPEAK OUT!<sup>®</sup> with the LOUD Crowd<sup>®</sup>Alison Behrman, Jennifer Cody, Shilpa Chitnis, et al.
Parkinsonism & Related Disorders|April 10, 2023
Early-onset Parkinson's disease: An assessment of unmet psychosocial needsBradley McDaniels, Indu Subramanian, Shelley Kurian, et al.
JAMA Neurology|February 15, 2013
History, applications, and mechanisms of deep brain stimulationSvjetlana Miocinovic, Suvarchala Somayajula, Shilpa Chitnis, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Ropinirole treatment for restless legs syndromeShilpa Chitnis
Neurologic Clinics|December 5, 2008
Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairmentShilpa Chitnis
Expert Opinion on Drug Metabolism & Toxicology|July 22, 2009
Rivastigmine in Parkinson's disease dementiaShilpa Chitnis, Jayaraman Rao
Life Sciences|June 27, 2002
Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cellsShilpa Chitnis, Debasis Mondal, Krishna C Agrawal
Archives of Neurology|August 11, 2010
Deep brain stimulation artifact in needle electromyographyHamid Sadeghian, Shilpa Chitnis, Jeffrey L Elliott
The International Journal of Neuroscience|August 26, 2011
Outcomes from switching from rotigotine patch to alternate therapies in Parkinson's diseaseShilpa Chitnis, Manall Jaffery, Richard B Dewey
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2021
An Online Education Method for Movement Disorders During COVID-19: Opportunity and ExperienceAbhimanyu Mahajan, Rasheda El-Nazer, Shilpa Chitnis
Logopedics, Phoniatrics, Vocology|August 2, 2021
Dysarthria treatment for Parkinson's disease: one-year follow-up of SPEAK OUT!<sup>®</sup> with the LOUD Crowd<sup>®</sup>Alison Behrman, Jennifer Cody, Shilpa Chitnis, et al.
Parkinsonism & Related Disorders|April 10, 2023
Early-onset Parkinson's disease: An assessment of unmet psychosocial needsBradley McDaniels, Indu Subramanian, Shelley Kurian, et al.
JAMA Neurology|February 15, 2013
History, applications, and mechanisms of deep brain stimulationSvjetlana Miocinovic, Suvarchala Somayajula, Shilpa Chitnis, et al.
Pageof 3